Emerald Advisers, LLC Black Diamond Therapeutics, Inc. Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021
SELL
$29.47 - $35.0 $77,889 - $92,505
-2,643 Closed
0 $0
Q3 2020

Oct 28, 2020
SELL
$26.17 - $43.07 $2.99 Million - $4.92 Million
-114,307 Reduced 97.74%
2,643 $80,000
Q2 2020

Jul 28, 2020
BUY
$22.3 - $44.8 $54,858 - $110,208
2,460 Added 2.15%
116,950 $4.93 Million
Q1 2020

Apr 30, 2020
BUY
$18.18 - $39.48 $2.08 Million - $4.52 Million
114,490 New
114,490 $2.86 Million

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $99.6M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email